← Leaderboards
David L Goldman
Virginia Commonwealth University
$1,535,474
Attributed
$1,535,474
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,535,474 · 2
By mechanism
R01$1,494,263 · 1
P30$41,211 · 1
Top collaborators
No co-investigators on record.
Most similar at Virginia Commonwealth University
Same institution · by research overlap
- Mitchell L Shiffman$2,507,516
- Roy W Pickens$2,800,000
- John E Nestler$6,116,076
- Iris A Camacho$85,052
- William W Campbell$648
Others in their field
Top investigators on “Aids Therapy”
- Lawrence Corey · Fred Hutchinson Cancer Center$356,191,804
- Constance Ann Benson · University Of California, San Diego$277,003,036
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$262,875,323
- Barbara Driver · Westat, Inc.$205,980,213
- Sharon A Nachman · Johns Hopkins University$193,704,208
- Carol Nesel · Westat$188,148,170
Research focus
Aids TherapyAlveolar MacrophagesAntifungal AntibodyPolysaccharidesRespiratory InfectionsChronic Disease /DisorderCryptococcosisCryptococcus NeoformansCytokineDisease /Disorder ModelGranulomaImmunotherapyLaboratory RatLeukocyte Activation /TransformationMicroorganism Disease ChemotherapyMonoclonal AntibodyNonhuman Therapy EvaluationOpportunistic InfectionsPathologic ProcessBiomedical FacilityHealth Science Research Support
Grant awards (5)
PATHOGENESIS OF C NEOFORMANS PERSISTENCE$375,750
R01 · FY2003 · HL
PATHOGENESIS OF C NEOFORMANS PERSISTENCE$375,750
R01 · FY2002 · HL
PATHOGENESIS OF C NEOFORMANS PERSISTENCE$376,688
R01 · FY2001 · HL
PATHOGENESIS OF C NEOFORMANS PERSISTENCE$366,075
R01 · FY2000 · HL
CORE--DEVELOPMENTAL CORE$41,211
P30 · FY2000 · CA